Tengjun Biotechnology Corp. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tengjun Biotechnology Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q2 2023.
  • Tengjun Biotechnology Corp. Operating Income (Loss) for the quarter ending June 30, 2023 was -$428K, a 109% decline year-over-year.
  • Tengjun Biotechnology Corp. annual Operating Income (Loss) for 2022 was $16.1M.
  • Tengjun Biotechnology Corp. annual Operating Income (Loss) for 2021 was -$738K, a 10.8% decline from 2020.
  • Tengjun Biotechnology Corp. annual Operating Income (Loss) for 2020 was -$666K, a 1588% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$428K -$5.06M -109% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-15
Q1 2023 $576K +$250K +76.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q3 2022 $9.59M $4.88M +$4.99M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $4.6M $4.63M +$4.85M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-15
Q1 2022 -$251K $326K +$487K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$738K -$250K +$391K +61% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$1.13M -$108K -$101K -1538% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.03M -$219K -$212K -2787% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-09-16
Q1 2021 -$816K -$161K -$150K -1319% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$666K -$641K -$625K -3933% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$41.4K -$6.57K -$96 -1.48% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 -$41.3K -$7.6K -$1.21K -18.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-20
Q1 2020 -$40.1K -$11.4K -$611 -5.69% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-16
Q4 2019 -$39.5K -$15.9K -$9.74K -158% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-17
Q3 2019 -$29.8K -$6.47K -$362 -5.93% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-20
Q2 2019 -$29.4K -$6.39K +$1.13K +15% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-24
Q1 2019 -$30.5K -$10.7K -$618 -6.11% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-22
Q4 2018 -$29.9K -$6.15K Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$6.11K -$251 -4.29% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 -$7.52K +$1.32K +14.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 -$10.1K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q3 2017 -$5.86K +$5.59K +48.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-16
Q2 2017 -$8.84K Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q3 2016 -$11.5K Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2015 -$10.4K +$20.3K +66.2% Apr 1, 2015 Jun 30, 2015 10-Q 2015-11-13
Q1 2015 -$22.6K +$34.5K +60.5% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-15
Q2 2014 -$30.7K Apr 1, 2014 Jun 30, 2014 10-Q 2015-11-13
Q1 2014 -$57.1K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q1 2012 -$17.8K -$6.52K -57.9% Jan 1, 2012 Mar 31, 2012 10-Q 2012-04-19
Q3 2011 -$7.38K -$3.2K -76.7% Jul 1, 2011 Sep 30, 2011 10-Q 2011-10-19
Q1 2011 -$11.3K Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-19
Q3 2010 -$4.17K Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.